Continuing its strong sales performance this year into the third quarter has led Germany’s PharmaSGP GmbH to raise its guidance for 2024.
Growth In Germany And Italy Prompts PharmaSGP To Raise Guidance
PharmaSGP has added an additional €5m to the top-end of its sales guidance after recording a double-digit gain Italy and outpacing the growth of the OTC market in Germany.
